Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Quanziang Wang"'
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background Immune checkpoint inhibitors-induced myocarditis presents unique clinical challenges. Here, we assessed post-marketing safety of cytotoxic T-lymphocyte-associated protein-4 (CTLA-4), programmed cell death-1 (PD-1), and programmed
Externí odkaz:
https://doaj.org/article/b556c85e11d04b5a818e592a8c8623a3
Publikováno v:
BMC Cancer
BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
Background Immune checkpoint inhibitors-induced myocarditis presents unique clinical challenges. Here, we assessed post-marketing safety of cytotoxic T-lymphocyte-associated protein-4 (CTLA-4), programmed cell death-1 (PD-1), and programmed death-lig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38f22e49349d85d15137e6fb6b0f9889
http://europepmc.org/articles/PMC7791701
http://europepmc.org/articles/PMC7791701
Additional file 1: Table S1. A 2 × 2 Contingency Table for Disproportionality Analysis. Table S2. Signal Values of ICIs-Associated ADRs.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::137d961fdd27dba36ef6f65f4045e61d
Autor:
Ma, Rulan1 (AUTHOR), Wang, Quanziang2 (AUTHOR), Meng, Deyu2 (AUTHOR), Li, Kang1 (AUTHOR) healthlee@xjtu.edu.cn, Zhang, Yong1 (AUTHOR) yongzhang761@mail.xjtu.edu.cn
Publikováno v:
BMC Cancer. 1/7/2021, Vol. 21 Issue 1, p1-9. 9p.